(vianews) - the market ended the session with medincell (medcl.pa) jumping 14.41% to €10.16 on tuesday, following the last session's downward trend. cac 40 slid 1.45% to €7,383.20, after two consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.
medincell's last close was €8.88, 14.29% below its 52-week high of €10.36.
about medincell
medincell s.a. develops various therapeutic solutions in france. it develops solutions based on bepo, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. the company's products in development include mdc-irm, a risperidone extended-release injectable suspension completed phase iii trial for use in the treatment of schizophrenia; mdc-cwm, a sustained-release formulation of celecoxib in phase iii trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-tjk, a subcutaneous injection in phase iii trials for use in the treatment of schizophrenia. its product candidates in preclinical trials, such as mdc-ang, an antipsychotic product for use in the treatment of schizophrenia; mdc-ttg for covid-19 and its variants; mdc-grt for use in organ transplant; mdc-wwm for contraception; mdc-stm for use in malaria; mdc-kpt for use in acute pain for pets; and mdc-irm for use in neuroscience. the company was incorporated in 2003 and is based in jacou, france.
earnings per share
as for profitability, medincell has a trailing twelve months eps of €-1.05.
stock price classification
according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, medincell's stock is considered to be oversold (<=20).
yearly top and bottom value
medincell's stock is valued at €10.16 at 22:35 est, below its 52-week high of €10.36 and way above its 52-week low of €4.73.
moving average
medincell's worth is way above its 50-day moving average of €8.92 and way higher than its 200-day moving average of €6.80.volume
today's last reported volume for medincell is 541200 which is 1135.64% above its average volume of 43799.
more news about medincell (medcl.pa).